|
|
GENETIC AND EPIGENETIC ENGINEERING FOR DOWN SYNDROME AND ASSOCIATED ALZHEIMER CELL PATHOLOGY |
| 1F32AG056131-01 |
VALLEDOR CEBALLOS, MELVYS |
NIA |
2017 |
|
|
EMOTION-INDUCED INHIBITION IN AGING AND ALZHEIMER'S DISEASE |
| 1F32AG057162-01 |
KENNEDY, BRIANA |
NIA |
2017 |
|
|
PREDICTORS AND LONG-TERM HEALTH OUTCOMES ASSOCIATED WITH COGNITIVE AND PHYSICAL DECLINE IN OLDER ADULTS |
| 1F32AG058457-01 |
HANDING, ELIZABETH |
NIA |
2017 |
|
|
THE ROLE OF CELL DEATH PATHWAYS IN MEDIATING NEURONAL LOSS DURING THE EARLIEST STAGES OF ALZHEIMER DISEASE |
| 1K01AG053433-01A1 |
THEOFILAS, PANAGIOTIS |
NIA |
2017 |
|
|
BILATERAL BRAIN DYNAMICS SUPPORTING COGNITION IN NORMAL AGING AND DEMENTIA |
| 1K01AG053539-01A1 |
DAVIS, SIMON W |
NIA |
2017 |
|
|
ROLE AND MECHANISM OF HEARING IMPAIRMENT IN COGNITIVE DECLINE AND DEMENTIA |
| 1K01AG054693-01A1 |
DEAL, JENNIFER ANNE |
NIA |
2017 |
|
|
NAD+ THERAPY FOR IMPROVING MEMORY & CEREBROVASCULAR FUNCTION IN PATIENTS WITH MCI |
| 1K01AG054731-01A1 |
MARTENS, CHRISTOPHER |
NIA |
2017 |
|
|
IMPLEMENTATION AND VALIDATION OF AN ONLINE CAREGIVER AND STUDY PARTNER PORTAL FOR ASSESSMENT OF COGNITIVE FUNCTION IN OLDER ADULTS |
| 1K01AG055692-01 |
NOSHENY, RACHEL LAUREN |
NIA |
2017 |
|
|
RECEPTOR-MEDIATED CLEARANCE OF SYNAPTIC TAU AS A NOVEL THERAPY FOR ALZHEIMER'S DISEASE. |
| 1K01AG055694-01 |
MYEKU, NATURA |
NIA |
2017 |
|
|
TREATMENT STRATEGIES IN GERIATRIC EPILEPSY |
| 1K08AG053380-01A1 |
MOURA, LIDIA MARIA VERAS ROCHA DE |
NIA |
2017 |
